VCIM
Velan Capital Investment Management Portfolio holdings
AUM
$99.9M
This Quarter Return
+3.81%
1 Year Return
+37.46%
3 Year Return
+659.14%
5 Year Return
–
10 Year Return
–
AUM
$92.1M
AUM Growth
+$92.1M
(-47%)
Cap. Flow
-$72.9M
Cap. Flow
% of AUM
-79.12%
Top 10 Holdings %
Top 10 Hldgs %
92.98%
Holding
23
New
5
Increased
3
Reduced
3
Closed
5
Top Buys
| 1 |
Liquidia Corp
LQDA
|
$3M |
| 2 |
scPharmaceuticals
SCPH
|
$2.36M |
| 3 |
Zevra Therapeutics
ZVRA
|
$1.39M |
| 4 |
Corbus Pharmaceuticals
CRBP
|
$1.03M |
| 5 |
Tourmaline Bio
TRML
|
$311K |
Top Sells
| 1 |
ALIM
Alimera Sciences, Inc.
ALIM
|
$75.7M |
| 2 |
Outlook Therapeutics
OTLK
|
$1.82M |
| 3 |
ELEV
Elevation Oncology
ELEV
|
$1.61M |
| 4 |
Skye Bioscience
SKYE
|
$825K |
| 5 |
Jasper Therapeutics
JSPR
|
$716K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Jasper Therapeutics
JSPR
$45.5M
| $27M | 25.22% | 1,433,828 -38,076 | -3% | -$716K |
|
2
Praxis Precision Medicines
PRAX
$958M
| $20.2M | 18.87% | 350,666 | – | – |
|
3
Heron Therapeutics
HRTX
$207M
| $13.9M | 13% | 6,986,744 | – | – |
|
|
4
Tourmaline Bio
TRML
$601M
| $8.51M | 7.96% | 331,190 +12,110 | +4% | +$311K |
|
5
Rezolute
RZLT
$619M
| $3.88M | 3.63% | 800,000 | – | – |
|
|
6
Liquidia Corp
LQDA
$2.38B
| $3M | 2.81% | +300,000 | New | +$3M |
|
7
Context Therapeutics
CNTX
$75.4M
| $2.53M | 2.36% | 1,290,323 | – | – |
|
8
InspireMD
NSPR
$102M
| $2.42M | 2.27% | 904,029 | – | – |
|
|
9
scPharmaceuticals
SCPH
$295M
| $2.36M | 2.21% | +517,668 | New | +$2.36M |
|
10
TELA Bio
TELA
$70.5M
| $1.89M | 1.77% | 747,410 +1,323 | +0.2% | +$3.35K |
|
|
OPTN
11
DELISTED
OptiNose
OPTN
| $1.44M | 1.34% | 2,146,608 -346,222 | -14% | -$232K |
|
|
12
Zevra Therapeutics
ZVRA
$509M
| $1.39M | 1.3% | +200,000 | New | +$1.39M |
|
13
Protara Therapeutics
TARA
$120M
| $1.05M | 0.98% | 574,000 +94,000 | +20% | +$172K |
|
|
14
Corbus Pharmaceuticals
CRBP
$115M
| $1.03M | 0.96% | +50,000 | New | +$1.03M |
|
|
15
Skye Bioscience
SKYE
$108M
| $825K | 0.77% | 211,071 -211,071 | -50% | -$825K |
|
16
Kiora Pharmaceuticals
KPRX
$9.55M
| $447K | 0.42% | 122,223 | – | – |
|
17
Tenax Therapeutics
TENX
$27.3M
| $288K | 0.27% | +83,333 | New | +$288K |
|
|
ELEV
18
DELISTED
Elevation Oncology
ELEV
| – | – | -597,299 | Closed | -$1.61M |
|
|
19
Outlook Therapeutics
OTLK
$37.8M
| – | – | -247,084 | Closed | -$1.82M |
|
20
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – | 0 | – | – |
|
21
X4 Pharmaceuticals
XFOR
$84.2M
| – | – | -659,020 | Closed | -$382K |
|
|
ALIM
22
DELISTED
Alimera Sciences, Inc.
ALIM
| – | – | -13,608,533 | Closed | -$75.7M |
|
|
ASLN
23
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| – | – | -625,000 | Closed | -$188K |
|